EOLS — Evolus, Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Company fundamentals

MetricCached value
Price (USD)7.41
Market cap (USD)489,103,200
P/E-6.07
ROE (%)267.84
Net profit margin (%)-17.28
Revenue growth (%)11.61
Dividend yield (%)0

Price last refreshed: .

Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.

About Evolus, Inc.

Available company fundamentals for EOLS in Drug Manufacturers - Specialty & Generic. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.